Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE, DE000A2GS5D8

16.11.2022 - 07:33:43

EQS-News: Dermapharm Holding SE successfully maintains growth trend as planned

16.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: Dermapharm Holding SE Lil-Dagover-Ring 7 82031 Gr?nwald

Germany Phone: +49 (0)89 64 86-0 E-mail: ir@dermapharm.com Internet: ir.dermapharm.de ISIN: DE000A2GS5D8 WKN: A2GS5D Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange EQS News ID: 1488571 ? End of News EQS News Service

1488571??16.11.2022?CET/CEST

@ dgap.de